The burgeoning digital marketplace has presented novel avenues for accessing prescription drugs, including the stimulant Adderall, primarily recommended for attention deficit hyperactivity disorder (ADHD). While proponents of cognitive enhancement argue that these substances can augment focus and productivity, ethical concerns escalate surrounding